FASN and Ewing sarcoma: Moreover, Orlistat, a specific FASN inhibitor, potently inhibited cell proliferation both in vitro (Figure 6F) and in vivo (Figure 6G, Supplementary Figure S5D) where each mouse carried two explants formed by A673 cells, suggesting the biological importance of fatty-acid synthesis pathway in Ewing sarcoma cells.